{{Rsnum
|rsid=630431
|Gene=PCSK9
|Chromosome=1
|position=55061650
|Orientation=plus
|GMAF=0.3219
|Gene_s=PCSK9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 49.6 | 44.2 | 6.2
| HCB | 70.8 | 26.3 | 2.9
| JPT | 72.6 | 24.8 | 2.7
| YRI | 10.9 | 40.1 | 49.0
| ASW | 22.8 | 43.9 | 33.3
| CHB | 70.8 | 26.3 | 2.9
| CHD | 70.6 | 28.4 | 0.9
| GIH | 62.4 | 34.7 | 3.0
| LWK | 13.6 | 38.2 | 48.2
| MEX | 72.4 | 24.1 | 3.4
| MKK | 15.4 | 51.3 | 33.3
| TSI | 51.0 | 45.1 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22794791
|Title=Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}